Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3FP0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,758
Award facts
- Contract value 100% obligated
- $26,758.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,758.31 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector pens. This is a non-set-aside competitive award with a completion date of January 16, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used in cardiovascular disease management, particularly for patients with high cholesterol. This delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at $999,999,999.00 through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving federal medical procurement needs across the military and veterans healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order represents routine replenishment of a critical cardiovascular medication needed to support military treatment facilities and federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F3FP0?
SPE2DR26F3FP0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F3FP0 worth?
The government has obligated $26,758 on SPE2DR26F3FP0.
Is contract SPE2DR26F3FP0 an order under another contract?
Yes. SPE2DR26F3FP0 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FP0 competed?
The extent of competition for SPE2DR26F3FP0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award